Categories
Science Technology

Amneal to virtually participate at upcoming investor conferences

BRIDGEWATER, N.J. — (BUSINESS WIRE) — Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that its investor relations or management team will virtually attend the following investor conferences:

Jefferies London Healthcare Conference

November 18, 2021

Investor Relations Hosted Meetings

Goldman Sachs Global Sustainability Forum

November 30, 2021

Investor Relations Hosted Meetings

Evercore ISI 4th Annual HEALTHCONx Virtual Conference

December 1, 2021

Management Hosted Meetings

Presentation – 8:25 a.m. Eastern Time

The presentation at the Evercore Conference will begin at 8:25 AM Eastern Time and a live webcast will be accessible through the Investor Relations section of the Company’s website at https://investors.amneal.com. A replay of the webcast will be posted shortly after the call.

 

About Amneal

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is a fully-integrated pharmaceutical company focused on the development, manufacturing and distribution of generic and specialty drug products. The Company has operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States.

 

Amneal has an extensive portfolio of approximately 250 product families and is expanding its portfolio to include complex dosage forms, including biosimilars, in a broad range of therapeutic areas. The Company also markets a portfolio of branded pharmaceutical products through its Specialty segment focused principally on central nervous system and endocrine disorders.

 

The Company also owns 65% of AvKARE. AvKARE provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, primarily focused on serving the Department of Defense and the Department of Veterans Affairs. AvKARE is also a packager and wholesale distributor of pharmaceuticals and vitamins to its retail and institutional customers who are located throughout the United States focused primarily on offering 340b-qualified entities products to provide consistency in care and pricing. For more information, visit www.amneal.com.

Contacts

Tony DiMeo

Senior Director, Investor Relations

Anthony.DiMeo@amneal.com

Categories
Business

AM Best revises outlooks to negative for Ategrity Specialty Holdings LLC and its subsidiaries

OLDWICK, N.J. — (BUSINESS WIRE) — #insuranceAM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a-” (Excellent) of Ategrity Specialty Insurance Company (ASIC) and its affiliate, Sequentis Reinsurance Company Limited (Sequentis Re). Concurrently, AM Best has revised the outlook to negative from stable and affirmed the Long-Term ICR of “bbb-” (Good) of their holding company, Ategrity Specialty Holdings LLC (Ategrity). Ategrity and ASIC are domiciled in Wilmington, DE, USA, while Sequentis Re is domiciled in Hamilton, Bermuda.

The Credit Ratings (ratings) reflect Ategrity’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management (ERM).

 

The revision of the outlooks to negative reflects AM Best’s concern over recent underwriting volatility, which has resulted in pressure on the company’s operating performance and ERM fundamentals. While the company has made recent changes in senior management and is in the midst of executing a strategy with less inherent volatility, these changes still need to prove beneficial to the group’s underwriting performance in the intermediate term.

 

Ategrity exhibits a very strong level of balance sheet strength considering the execution risk inherent in the group’s operations. The group’s risk-adjusted capitalization, as measured by Best’s Capital Adequacy Ratio (BCAR), is considered strongest. Ategrity, which is in its third year of operation, has grown more than originally projected. Although capital levels have kept pace with the increased premium, the group has been subject to outsized catastrophe losses linked to their property exposure.

 

Prospective operating profitability is dependent on management’s ability to execute a revised business plan with a greater focus on lines of business with reduced catastrophe exposure and less inherent volatility. The group’s investment performance has been accretive to results.

 

Ategrity, through its U.S. operating subsidiary, ASIC, began writing excess and surplus lines of business in the fourth quarter of 2018. The group’s business profile is considered limited given its start-up status and shifting business plans, although management has strong existing industry relationships. The company is making enhancements to its ERM program, which are expected to lead to greater stability in its underwriting results.

 

Negative rating action could occur if Ategrity fails to improve its underwriting track record over the next cycle and falls short of projected performance. Continued significant underwriting volatility could also result in negative rating pressure on the assessment of the group’s ability to manage its risk exposures.

 

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

 

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

 

Copyright © 2021 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Clare Finnegan
Senior Financial Analyst
+1 908 439 2200, ext. 5165
clare.finnegan@ambest.com

Christopher Sharkey
Manager, Public Relations
+1 908 439 2200, ext. 5159
christopher.sharkey@ambest.com

Steven M. Chirico, CPA
Director
+1 908 439 2200, ext. 5087
steven.chirico@ambest.com

Jim Peavy
Director, Communications
+1 908 439 2200, ext. 5644
james.peavy@ambest.com

Categories
Healthcare Technology

New Clinical Study: Hinge Health Enso wearable demonstrates significant improvements in both mobility and pain reduction

University of California San Francisco and Memorial Sloan Kettering Cancer Center researchers publish randomized controlled study demonstrating Hinge Health Enso delivers 2x greater pain reduction and 3x improved mobility compared to control

 

SAN FRANCISCO — (BUSINESS WIRE) — A new randomized controlled clinical study finds that Hinge Health’s Enso delivers 2x more pain reduction and improves mobility 3x compared to a control device. Researchers from the University of California San Francisco and Memorial Sloan Kettering Cancer Center published the study in the Journal of Pain Research. Enso, an FDA-cleared device, is a wearable, nonaddictive, high-frequency impulse therapy technology for better pain management and functional mobility. The findings are a significant milestone as patients increasingly look for pain management alternatives. While there are decades of research on short-term pain reduction from lower-frequency devices, this is the first study demonstrating durable pain relief and improved functional mobility with a high-frequency impulse therapy device over a four-week time frame.


Hinge Health Enso is one of the most advanced wearable technologies for electrical nerve stimulation. Key findings from the four-week randomized controlled study include the following:

 

  • Enso participants decreased pain more than twice as much compared to the control group (-54.7% Enso vs. -25.3% control, p ≤ 0.05).
  • Enso participants had 2.5x more improvement in walking speed, as measured by the Six-Minute Walk Test (30.1% Enso vs. 12.3% control, p ≤ 0.05).
  • Enso participants improved mobility 3.4x, as measured by the Timed Up and Go Test (65.9% Enso vs. 19.4% control, p ≤ 0.05).

 

“Musculoskeletal pain is extremely common, with one in two Americans experiencing chronic back or joint pain in any given year. This study further validates the efficacy of Enso. Enso has already helped thousands by improving functional mobility and quickly delivering noninvasive, nonaddictive, lasting pain relief via an easy-to-use wearable,” said Dr. Jeffrey Krauss, Hinge Health’s chief medical officer.

 

A randomized controlled trial of the high-frequency impulse therapy device versus a control sham device was conducted with thirty-six patients seeking care for chronic low back pain from five orthopedic and pain center sites in California, USA. The clinical study was sponsored by Hinge Health.

 

About Hinge Health:

Hinge Health is building the world’s most patient-centered Digital Musculoskeletal (MSK) Clinic™. It is now the leading Digital MSK Clinic, used by four in five employers and 90% of health plans with a digital MSK solution. Hinge Health reduces MSK pain, surgeries, and opioid use by pairing advanced wearable sensors and computer vision technology with a comprehensive clinical care team of physical therapists, physicians, and board-certified health coaches. Hinge Health’s HingeConnect integrates with 750,000+ in-person providers and enables real-time interventions for elective MSK surgeries, driving proven medical claims reduction. Available to millions of members, Hinge Health is widely trusted by leading organizations, including Land O’Lakes, L.L. Bean, Salesforce, Self-Insured Schools of California, Southern Company, State of New Jersey, US Foods, and Verizon. Learn more at http://www.hingehealth.com.

Contacts

Meghan Doherty

media@hingehealth.com

Categories
Healthcare Technology

Castor appoints digital leader Milind Kamkolkar to Board of Directors

Industry veteran Milind Kamkolkar joins Castor’s Board of Directors to advance mission of democratizing clinical research by maximizing the impact of clinical data.

HOBOKEN, N.J. — (BUSINESS WIRE) — #DCTCastor, a leading provider of decentralized and hybrid clinical trial solutions, today announced the appointment of industry veteran Milind Kamkolkar to its Board of Directors.

 

Milind is currently Senior Advisor to Cellarity, a Flagship Pioneering Company, after his tenure as Chief Digital & Data Officer. He brings to Castor more than 20 years of experience in healthcare AI and digital health, from startup, management consulting to Fortune 500 enterprises. As a Board member, Milind will help Castor accelerate its goal of making the world’s research data more accessible, enabling AI-driven clinical trials, and ultimately use actionable data to improve the speed and efficiency of clinical trials.

 

“The adoption of decentralized clinical trials has seen exponential growth, catalyzing an industry in critical need of modernization,” said Milind. “I was impressed by the leadership, talent and technology at Castor, which complement the hard problems Castor’s platform tackles with technical sophistication. To support the growing clinical research needs of academic centers and life sciences companies, Castor’s technology simplifies the clinical trial process and ‘consumerizes’ new processes for tech-enabled clinical trials. I look forward to contributing my expertise and being a part of Castor’s journey to enable faster, smarter clinical trials.”

 

Castor offers a leading cloud-based clinical data platform that simplifies the clinical trial process, from recruitment to analysis, for global research. Castor’s combined Advisory Board & Board of Directors consists of twelve industry leaders that are committed to furthering the company’s mission to make clinical research smarter and faster through technology.

 

Castor’s Board has been instrumental in fueling Castor’s growth. Since 2014, Castor has supported over 8,500 studies in more than 90 countries. In the last two years, the company more than doubled in size and worked with customers such as the World Health Organization, which used Castor for its Solidarity Trial, landed contracts with over 30 top-tier digital therapeutics companies, and penned enterprise agreements with multiple top 5 pharmaceutical companies.

 

“We’ve made significant progress in advancing our clinical and technology and practices this year,” said Derk Arts, PhD, Chief Executive Officer and Founder of Castor. “We are thrilled to have Milind join our Board. His expertise, insights and passion for technology combined with the collective experience of our leadership team and Board, is critical to our ability to operationalize and achieve our vision of democratizing clinical research to maximize the impact of research data for patients worldwide.”

 

Milind joined Cellarity from Sanofi where he was the first enterprise Chief Data Officer in the pharmaceutical industry. Prior to Sanofi, he was the Head of AI and Data science within the Digital Medicines group at Novartis.

 

Castor’s current Board members include:

  • Derk Arts, Member, Founder & CEO Castor
  • Rob Konterman, Member, COO Castor
  • Ben Cons, Chairman, Advisor, Investor, Chairman/NED
  • Villi Iltchev, Member, Partner at Two Sigma Ventures
  • Corné Jansen, Member, Partner at INKEF Capital
  • Michael Treskow, Partner at Eight Roads Capital
  • Alex Pasteur, Partner at F-Prime

 

To read more about Castor’s Board of Directors, visit www.castoredc.com/about-us/leadership/.

 

About Castor

Castor is a leading provider of decentralized and hybrid clinical trial solutions to democratize research. With the highest-rated eClinical platform for decentralized and hybrid clinical trials, Castor’s plug-and-play platform offers rapid deployment at scale, enabling researchers to create a trial in a matter of clicks, with easy enrollment, eConsent, and real-world data capture. Castor is bringing human-centered design to the clinical trial process, from recruitment to analysis, and improving the quality, security, and reusability of data for researchers worldwide. For more information, visit www.castoredc.com. Follow us on Twitter at @castor.

Contacts

Media
Kimberly Ha

KKH Advisors

kimberly.ha@kkhadvisors.com

Categories
Business

TriState Capital hires Gene McCarthy as regional president of New Jersey office

PITTSBURGH & EDISON, N.J. — (BUSINESS WIRE) — TriState Capital Holdings, Inc. (Nasdaq: TSC) announced that Gene McCarthy has joined the company as TriState Capital Bank regional president, New Jersey. McCarthy is responsible for the region’s overall performance and future strategic direction as well as developing and growing new and existing commercial markets. He succeeds Ken Orchard, who retired earlier this year.


We are excited to add Gene’s leadership to our talented commercial banking team in New Jersey,” said TriState Capital Bank’s president and CEO, Brian Fetterolf. “His veteran experience and market knowledge make him the perfect fit for expanding our strong team, our support for our clients, and our presence in the market, where we focus on providing customized commercial lending and treasury management solutions.”

 

McCarthy has more than 20 years of financial services experience and most recently was first senior vice president and market executive with FirstBank. Earlier in his career, McCarthy was lead senior managing director and has also been director of real estate and commercial banking at various institutions.

 

I’m excited to join one of the fastest growing middle-market commercial banks in the country,” said McCarthy. “I’m eager to continue building relationships with current and potential clients as TriState Capital’s top-notch talent continues to provide creative solutions and outstanding customer service.”

 

McCarthy holds a Bachelor of Arts in economics from Bucknell University.

 

ABOUT TRISTATE CAPITAL

TriState Capital Holdings, Inc. (Nasdaq: TSC) is a bank holding company headquartered in Pittsburgh, Pa., providing commercial banking, private banking and investment management services to middle-market companies, institutional clients and high-net-worth individuals. Its TriState Capital Bank subsidiary had $12.07 billion in assets as of September 30, 2021, and serves middle-market commercial customers through regional representative offices in Pittsburgh, Philadelphia, Cleveland, Edison, N.J., and New York City, as well as high-net-worth individuals nationwide through its national referral network of financial intermediaries. Its Chartwell Investment Partners subsidiary had $11.45 billion in assets under management as of September 30, 2021, and serves institutional clients and TriState Capital’s financial intermediary network. For more information, please visit http://investors.tristatecapitalbank.com.

Contacts

MEDIA CONTACT
Jeff Shurilla

Hornercom

215-764-2376

jeff@hornercom.com

INVESTOR CONTACT
Jeff Schoenborn

Lambert

888-609-8351

TSC@lambert.com

Categories
Business Environment

Best’s Market Segment Report: Insurers’ incurred asbestos losses declined in 2020; A&E exposures estimate remains on target

OLDWICK, N.J. — (BUSINESS WIRE) — Annual incurred asbestos losses continued to decline in 2020, although overall asbestos and environmental (A&E) incurred losses were up slightly for the year as the environmental side saw an uptick, according to a new AM Best report.

The Best’s Market Segment Report, titled, “Insurers’ A&E Incurred Losses Still Declining; Funding Remains on Target,” states that annual incurred A&E losses rose slightly by nearly 2% in 2020 to $1.8 billion, following a drop of approximately 7% in 2019. Prior to 2020, annual incurred A&E losses had declined each year since 2017. Larger insurance groups that reported much lower asbestos incurred losses in 2020 than in 2019 drove the decrease in incurred asbestos losses. Incurred environmental losses were particularly low in 2019, so the $100 million uptick in 2020 represented a 10% increase.

 

AM Best is maintaining its estimate for net A&E losses at $146 billion – $100 billion in net asbestos losses and $46 billion in net environmental losses. Loss payments continue to outpace incurred losses. Over the past five years, the industry has paid out approximately $15 billion for A&E claims, while incurring more than $10 billion in losses. Given the relatively high-but-declining level of paid and incurred losses, AM Best expects its ultimate estimate to remain on target. Fifteen insurers account for 89% of the industry’s average annual A&E incurred losses, with Travelers Group at the top of the list, followed by Hartford Insurance Group and Berkshire Hathaway Insurance Group, Inc.

 

Insurers’ asbestos reserves in 2020 declined by approximately 3%, to $17.1 billion. Environmental reserves declined by a little more than 7%, to $4.9 billion. Industry funding of net A&E exposures is approximately $135 billion—$113 billion in cumulative paid-to-date losses and the $22 billion in reserves. This translates into a funding rate of approximately 93% of ultimate A&E exposures. At current payout levels, AM Best expects A&E reserves to run off within approximately eight years, barring any additional reserve strengthening.

 

AM Best utilizes a combination of three approaches when evaluating an insurer’s A&E reserve adequacy: historic premium market share, post-1990 paid loss share (1991–2020) and three-year survival ratios. The A&E-related figures are for the three main segments of the U.S. property/casualty industry: commercial, personal and reinsurance lines. The commercial lines segment holds approximately 63% of the industry’s net A&E reserves, while reinsurers hold approximately 25% and personal lines insurers the remaining 12%.

 

AM Best recognizes that fully funding ultimate estimates is extremely difficult, given the improvement in therapies, emerging drug combinations and early diagnosis, combined with ongoing mass tort litigation, but views the majority of insurers with material A&E exposures as well-capitalized and able to absorb any shortfalls.

 

To access the full copy of this market segment report, please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=314593.

 

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

 

Copyright © 2021 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Jieqiu Fan
Senior Financial Analyst
+1 908 439 2200, ext. 5372
jieqiu.fan@ambest.com

Brian O’Larte
Director
+1 908 439 2200, ext. 5138
brian.o’larte@ambest.com

Christopher Sharkey
Manager, Public Relations
+1 908 439 2200, ext. 5159
christopher.sharkey@ambest.com

Jim Peavy
Director, Communications
+1 908 439 2200, ext. 5644
james.peavy@ambest.com

Categories
Business Sports & Gaming

MSG Sports and MSG Entertainment announce multi-year marketing partnership with BetMGM

BetMGM Named an Official Sports Betting Partner of

the Knicks, Rangers and Madison Square Garden Arena

BetMGM to Receive Significant Exposure Throughout Knicks and Rangers Games at The Garden; Will Also be Featured Throughout Knicks, Rangers, Devils and Islanders Broadcasts

on MSG Networks

Partnership Marks MSG Sports’ and MSG Entertainment’s

First Comprehensive Foray into Mobile Sports Gaming

 

NEW YORK — (BUSINESS WIRE) — Madison Square Garden Sports Corp. (NYSE: MSGS) (“MSG Sports”) and Madison Square Garden Entertainment Corp. (NYSE: MSGE) (“MSG Entertainment”) announced today a multi-year marketing partnership with BetMGM, naming the sports betting and gaming entertainment company an Official Sports Betting Partner of the New York Knicks, New York Rangers and Madison Square Garden Arena.

We’re excited to be partnering with BetMGM – a leader in the sports betting and gaming entertainment industry – to bring them an unparalleled platform in sports and entertainment,” said Ron Skotarczak, Executive Vice President, Marketing Partnerships, MSG Entertainment. “MSG Sports and MSG Entertainment are made up of world-renowned brands that set industry standards for excellence, exposure and engagement– making us ideal partners to help drive sports betting’s continued growth.”

 

We’re thrilled to see the BetMGM brand connected to a space as iconic as Madison Square Garden,” said Matt Prevost, Chief Revenue Officer, BetMGM. “New York is a critical state for BetMGM’s continued growth and I can’t think of a better way to begin our relationship with The Empire State than partnering with The World’s Most Famous Arena and their legendary team franchises.”

 

As part of the marketing partnership, BetMGM will receive substantial brand integration inside The Garden including courtside and ribbon LED signage, GardenVision features and basket stanchion signage at Knicks games, along with dasherboard signage and Zamboni branding at Rangers games. Additionally, BetMGM will be included in content across official Knicks and Rangers digital channels on Twitter, Instagram and Facebook, and BetMGM customers will receive special opportunities to participate in premium experiences at Knicks and Rangers games.

 

BetMGM will also be featured prominently on MSG Networks during live game coverage of the Knicks, Rangers, New Jersey Devils and New York Islanders, highlighted by a virtual blue line during Rangers games and commercials spots during game telecasts. In addition, BetMGM will appear on digital boards outside of The Garden and MSG Networks, which are on display to the millions of people who walk by The Garden every day.

 

About Madison Square Garden Sports Corp.

Madison Square Garden Sports Corp. (MSG Sports) (NYSE: MSGS) is a leading professional sports company, with a collection of assets that includes: the New York Knicks (NBA) and the New York Rangers (NHL); two development league teams – the Westchester Knicks (NBAGL) and the Hartford Wolf Pack (AHL); and esports teams through Counter Logic Gaming, a leading North American esports organization, and Knicks Gaming, an NBA 2K League franchise. MSG Sports also operates two professional sports team performance centers – the MSG Training Center in Greenburgh, NY and the CLG Performance Center in Los Angeles, CA. More information is available at www.msgsports.com.

 

About Madison Square Garden Entertainment Corp.

Madison Square Garden Entertainment Corp. (MSG Entertainment) is a leader in live entertainment. The Company presents or hosts a broad array of events in its diverse collection of venues: New York’s Madison Square Garden, Hulu Theater at Madison Square Garden, Radio City Music Hall and Beacon Theatre; and The Chicago Theatre. MSG Entertainment is also building a new state-of-the-art venue in Las Vegas, MSG Sphere at The Venetian. In addition, the Company features the original production – the Christmas Spectacular Starring the Radio City Rockettes – and through Boston Calling Events, produces the Boston Calling Music Festival. The Company’s two regional sports and entertainment networks, MSG Network and MSG+, deliver a wide range of live sports content and other programming. Also under the MSG Entertainment umbrella is Tao Group Hospitality, with entertainment dining and nightlife brands including: Tao, Marquee, Lavo, Beauty & Essex, Cathédrale, Hakkasan and Omnia. More information is available at www.msgentertainment.com.

 

About BetMGM

BetMGM is a market leading sports betting and gaming entertainment company, pioneering the online gaming industry. Born out of a partnership between MGM Resorts International (NYSE: MGM) and Entain Plc (LSE: ENT), BetMGM has exclusive access to all of MGM Resorts’ U.S. land-based and online sports betting, major tournament poker, and online gaming businesses. Utilizing Entain’s U.S.-licensed, state of the art technology, BetMGM offers sports betting and online gaming via market leading brands including BetMGM, Borgata Casino, Party Casino and Party Poker. Founded in 2018, BetMGM is headquartered in New Jersey. For more information, visit http://www.betmgminc.com/.

Contacts

MSG Contact:

Ryan Watson/212-465-5945

Ryan.Watson@msgsports.com

BetMGM Contact:

Elisa Richardson/609-500-9880

Elisa.Richardson@betmgm.com

Categories
Business

Cherry Hill Mortgage Investment Corporation announces third quarter 2021 results

FARMINGDALE, N.J. — (BUSINESS WIRE) — Cherry Hill Mortgage Investment Corporation (NYSE: CHMI) (“Cherry Hill” or the “Company”) today reported results for the third quarter 2021.

 

Third Quarter 2021 Highlights

  • GAAP net loss applicable to common stockholders of $6.2 million, or $0.36 per share
  • Earnings available for distribution (“EAD”, fka “core earnings”) attributable to common stockholders of $4.2 million, or $0.25 per share. Earnings available for distribution included a one-time payment of $0.03 per share related to the Company’s mortgage servicer Aurora
  • Common book value per share of $9.07 at September 30, 2021
  • Declared regular common dividend of $0.27 per share, annualized common dividend yield at market close was 11.8% at November 8, 2021
  • Aggregate portfolio leverage stood at 3.2x at September 30, 2021
  • As of September 30, 2021, the Company had unrestricted cash of $62.9 million

 

“During the quarter, we continued to benefit from gradually improving prepayment speeds,” said Jay Lown, President and Chief Executive Officer of Cherry Hill Mortgage Investment Corporation. “We believe rates have stabilized at a higher level and anticipate that our portfolio will benefit from a rising rate environment.”

 

Operating Results

Cherry Hill reported GAAP net loss applicable to common stockholders for the third quarter of 2021 of $6.2 million, or $0.36 per basic and diluted weighted average common share outstanding. Reported GAAP net loss was determined based primarily on the following: $6.4 million of net interest income, $10.8 million of net servicing income, a net realized loss of $1.0 million on RMBS, a net realized loss of $3.0 million on derivatives, a minimal net realized loss on acquired assets, a net unrealized loss of $5.5 million on derivatives, a net unrealized loss of $7.9 million on Servicing Related Assets, and general and administrative expenses and management fees paid to Cherry Hill’s external manager in the aggregate amount of $3.7 million.

 

Earnings available for distribution attributable to common stockholders for the third quarter of 2021 were $4.2 million, or $0.25 per basic and diluted weighted average common share outstanding. For a reconciliation of GAAP net loss to non-GAAP earnings available for distribution, please refer to the reconciliation table accompanying this release.

Three Months Ended

September 30,

2021

2020

(unaudited)

(unaudited)

Income

Interest income

$

7,043

$

10,001

Interest expense

646

(18)

Net interest income

6,397

10,019

Servicing fee income

13,839

14,365

Servicing costs

3,080

5,266

Net servicing income

10,759

9,099

Other income (loss)

Realized gain (loss) on RMBS, available-for-sale, net

(1,050)

6,722

Realized loss on derivatives, net

(3,023)

(7,841)

Realized loss on acquired assets, net

(19)

(95)

Unrealized gain (loss) on derivatives, net

(5,467)

3,702

Unrealized loss on investments in Servicing Related Assets

(7,914)

(20,972)

Total Income (Loss)

(317)

634

Expenses

General and administrative expense

1,729

1,503

Management fee to affiliate

1,959

1,989

Total Expenses

3,688

3,492

Loss Before Income Taxes

(4,005)

(2,858)

Benefit from corporate business taxes

(215)

(2,116)

Net Loss

(3,790)

(742)

Net loss allocated to noncontrolling interests in Operating Partnership

77

10

Dividends on preferred stock

2,462

2,459

Net Loss Applicable to Common Stockholders

$

(6,175)

$

(3,191)

Net Loss Per Share of Common Stock

Basic

$

(0.36)

$

(0.19)

Diluted

$

(0.36)

$

(0.19)

Weighted Average Number of Shares of Common Stock Outstanding

Basic

17,185,872

17,054,634

Diluted

17,206,086

17,076,858

_______________

Dollar amounts in thousands, except per share amounts. Certain prior period amounts have been reclassified to conform to current period presentation.

Net unrealized gain on the Company’s RMBS portfolio for the third quarter 2021 was approximately $1.6 million.

Three Months Ended

September 30,

2021

2020

(unaudited)

(unaudited)

Net Loss

$

(3,790)

$

(742)

Other comprehensive income (loss):

Net unrealized gain on RMBS

512

4,612

Reclassification of net realized gain (loss) on RMBS included in earnings

1,050

(6,722)

Other comprehensive income (loss)

1,562

(2,110)

Comprehensive loss

$

(2,228)

$

(2,852)

Comprehensive loss attributable to noncontrolling interests in Operating Partnership

(42)

(49)

Dividends on preferred stock

2,462

2,459

Comprehensive loss attributable to common stockholders

$

(4,648)

$

(5,262)

_______________

Dollar amounts in thousands. Certain prior period amounts have been reclassified to conform to current period presentation.

 

Portfolio Highlights for the Quarter Ended September 30, 2021

The Company realized net servicing fee income of $10.8 million and net interest income of $6.4 million, offset by other expenses of $17.5 million, primarily related to unrealized losses on investments in Servicing Related Assets, as well as unrealized and realized losses on derivatives. The unpaid principal balance for the MSR portfolio stood at $20.8 billion as of September 30, 2021 and the carrying value of the MSR portfolio ended the quarter at $210.8 million. Net interest spread for the RMBS portfolio stood at 2.26% and the debt-to-equity ratio on the aggregate portfolio ended the quarter at 3.2x.

 

The RMBS portfolio had a book value of approximately $850.0 million and carrying value of approximately $865.9 million at quarter-end September 30, 2021. The portfolio had a weighted average coupon of 3.07% and weighted average maturity of 28 years.

 

In order to mitigate duration risk and interest rate risk associated with the Company’s RMBS and MSRs, Cherry Hill used interest rate swaps, swaptions, TBAs, Treasury futures and options on Treasury futures. At quarter end September 30, 2021, the Company held interest rate swaps with a notional amount of $1.4 billion, swaptions with a notional amount of $55.0 million, TBAs with a notional amount of $536.0 million, Treasury futures with a notional amount of ($30.0) million, and options on Treasury futures with a notional amount of $50.0 million.

 

As of September 30, 2021, Cherry Hill’s GAAP book value was $9.07 per diluted share, net of the third quarter dividend.

 

Dividends

On September 17, 2021, the Board of Directors declared a quarterly dividend of $0.27 per share of common stock for the third quarter of 2021. The dividend was paid in cash on October 26, 2021 to common stockholders of record as of the close of business on September 30, 2021. Additionally, the Board of Directors declared a dividend of $0.5125 per share on the Company’s 8.20% Series A Cumulative Redeemable Preferred Stock and $0.515625 per share on the Company’s 8.250% Series B Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock for the third quarter of 2021. The dividends were paid in cash on October 15, 2021 to Series A and B Preferred stockholders of record as of the close of business on September 30, 2021.

 

Earnings Available for Distribution (formerly known as Core Earnings)

Beginning with this quarter, the Company has retitled core earnings as earnings available for distribution or EAD. In connection with the retitling, no changes were made to the method of calculating core earnings, now called EAD. EAD is a non-GAAP financial measure and is currently defined by the Company as GAAP net income (loss), excluding realized gain (loss) on RMBS, realized and unrealized gain (loss) on investments in MSRs (net of any estimated MSR amortization), realized and unrealized gain (loss) on derivatives and realized (gain) loss on acquired assets. EAD is adjusted to exclude outstanding LTIP-OP Units in our Operating Partnership and dividends paid on preferred stock. MSR amortization refers to the portion of the change in fair value of the MSRs that is primarily due to the realization of cashflows or runoff and includes an adjustment for any gain or loss on the capital used to purchase the MSR. Additionally, EAD excludes any tax (benefit) expense on realized and unrealized gain (loss) on MSRs. EAD are provided for purposes of potential comparability to other issuers that invest in residential mortgage-related assets. The Company believes providing investors with EAD, in addition to related GAAP financial measures, may provide investors some insight into the Company’s ongoing operational performance. However, the concept of EAD does have significant limitations, including the exclusion of realized and unrealized gains (losses), and given the apparent lack of a consistent methodology among issuers for defining EAD, it may not be comparable to similarly-titled measures of other issuers, which define EAD differently from the Company and each other. As a result, EAD should not be considered a substitute for the Company’s GAAP net income (loss) or as a measure of the Company’s liquidity. While EAD is one indicia of the Company’s earnings capacity, it is not the only factor considered in setting a dividend and is not the same as REIT taxable income which is calculated in accordance with the rules of the IRS.

 

The following table provides a reconciliation of net income (loss) to EAD for the three months ended September 30, 2021 and 2020:

Three Months Ended

September 30,

2021

2020

(unaudited)

(unaudited)

Net Loss

$

(3,790)

$

(742)

Realized loss (gain) on RMBS, net

1,050

(6,722)

Realized loss on derivatives, net

3,023

7,841

Realized loss on acquired assets, net

19

95

Unrealized loss (gain) on derivatives, net

5,467

(3,702)

Unrealized loss on investments in MSRs, net of estimated MSR amortization

417

15,091

Tax (benefit) expense on realized and unrealized (loss) gain on MSRs

655

(1,017)

Total EAD:

$

6,841

$

10,844

EAD attributable to noncontrolling interests in Operating Partnership

(134)

(198)

Dividends on preferred stock

2,462

2,459

EAD Attributable to Common Stockholders

$

4,245

$

8,187

EAD Attributable to Common Stockholders, per Diluted Share

$

0.25

$

0.48

GAAP Net Loss Per Share of Common Stock, per Diluted Share

$

(0.36)

$

(0.19)

_________

Dollar amounts in thousands, except per share amounts. Certain prior period amounts have been reclassified to conform to current period presentation.

 

Additional Information

Additional information regarding Cherry Hill’s financial condition and results of operations can be found in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 filed with the Securities and Exchange Commission on November 9, 2021. In addition, an investor presentation with supplemental information regarding Cherry Hill, its business and its financial condition as of September 30, 2021 and its results of operations for the third quarter 2021 has been posted to the Investor Relations section of Cherry Hill’s website, www.chmireit.com. Cherry Hill will discuss the investor presentation on the conference call referenced below.

 

Webcast and Conference Call

The Company’s management will host a conference call today at 5:00 P.M. Eastern Time. A copy of this earnings release and the investor presentation referenced above will be posted to the Investor Relations section of Cherry Hill’s website, www.chmireit.com. All interested parties are welcome to participate on the live call. A simultaneous webcast of the conference call will be available to the public on a listen-only basis at www.chmireit.com. Please allow extra time prior to the call to visit the site and download any necessary software required to listen to the webcast.

 

The conference call may be accessed by dialing 1-877-344-8082 (from within the U.S.) or 1-213-992-4618 (from outside of the U.S.) ten minutes prior to the scheduled start of the call; please reference “Cherry Hill Third Quarter 2021 Earnings Call.”

 

A telephonic replay of the conference call will also be available two hours following the completion of the call through 11:59 P.M. Eastern Time on December 9, 2021 by dialing 1-844-512-2921 (from within the U.S.) or 1-412-317-6671 (from outside of the U.S.); please enter replay pin number “147451.”

 

About Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corporation is a real estate finance company that acquires, invests in and manages residential mortgage assets in the United States. For additional information, visit www.chmireit.com.

 

Forward-Looking Statements

This press release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including, among others, statements relating to the Company’s long-term growth opportunities and strategies, expand its market opportunities and create its own Excess MSRs and its ability to generate sustainable and attractive risk-adjusted returns for stockholders. These forward looking statements are based upon the Company’s present expectations, but these statements are not guaranteed to occur. For a description of factors that may cause the Company’s actual results or performance to differ from its forward-looking statements, please review the information under the heading “Risk Factors” included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, and other documents filed by the Company with the Securities and Exchange Commission.

Contacts

Cherry Hill Mortgage Investment Corporation

Investor Relations

(877) 870-7005

InvestorRelations@chmireit.com

Categories
Business

Prudential Financial announces quarterly dividend and 2022 share repurchase authorization

NEWARK, N.J. — (BUSINESS WIRE) — Prudential Financial, Inc. (NYSE: PRU) announced today the declaration of a quarterly dividend of $1.15 per share of Common Stock, payable on December 16, 2021, to shareholders of record at the close of business on November 23, 2021.

Additionally, Prudential’s Board of Directors has authorized the repurchase of up to $1.5 billion of its outstanding Common Stock during the period from January 1, 2022 through December 31, 2022.

 

The timing and amount of any share repurchases under the Company’s share repurchase authorization will be determined by management based on market conditions and other considerations, and such repurchases may be executed in the open market, through derivative, accelerated repurchase and other negotiated transactions and through plans designed to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.

 

Prudential Financial, Inc. (NYSE: PRU), a global financial services leader and premier active global investment manager with more than $1.5 trillion in assets under management as of September 30, 2021, has operations in the United States, Asia, Europe, and Latin America. Prudential’s diverse and talented employees help make lives better by creating financial opportunity for more people. Prudential’s iconic Rock symbol has stood for strength, stability, expertise and innovation for more than a century. For more information, please visit news.prudential.com.

Contacts

Julie Laskin

973-802-3975

julie.laskin@prudential.com

Categories
Art & Life Business

Mortgage delinquency continues to sink as pandemic recedes, CoreLogic reports

Homeowners look to income growth and home equity wealth to manage their mortgage debt

 

IRVINE, Calif. — (BUSINESS WIRE) — CoreLogic, a leading global property information, analytics and data-enabled solutions provider, today released its monthly Loan Performance Insights Report for August 2021.


For the month of August, 4% of all mortgages in the U.S. were in some stage of delinquency (30 days or more past due, including those in foreclosure), representing a 2.6-percentage point decrease in delinquency compared to August 2020, when it was 6.6%.

 

To gain a complete view of the mortgage market and loan performance health, CoreLogic examines all stages of delinquency. In August 2021, the U.S. delinquency and transition rates, and their year-over-year changes, were as follows:

 

  • Early-Stage Delinquencies (30 to 59 days past due): 1.1%, down from 1.5% in August 2020.
  • Adverse Delinquency (60 to 89 days past due): 0.3%, down from 0.8% in August 2020.
  • Serious Delinquency (90 days or more past due, including loans in foreclosure): 2.6%, down from 4.3% in August 2020.
  • Foreclosure Inventory Rate (the share of mortgages in some stage of the foreclosure process): 0.2%, down from 0.3% in August 2020. This remains the lowest foreclosure rate recorded since CoreLogic began recording data (1999).
  • Transition Rate (the share of mortgages that transitioned from current to 30 days past due): 0.6%, down from 0.9% in August 2020.

 

Facing slower than anticipated employment growth — August saw an increase of only 235,000 new jobs compared to the expected 720,000 — households have found creative ways to cut back on spending to prioritize mortgage payments. In a recent CoreLogic survey, over 30% of respondents said they would cut back on both entertainment and travel to focus on repaying outstanding debt. Income growth and a continued buildup in home-equity wealth will be important parts of financial recovery for borrowers hit hardest by the pandemic.

 

“The unprecedented fiscal and monetary stimuli that have been implemented to combat the pandemic are pushing housing prices and home equity to record levels,” said Frank Martell, president and CEO of CoreLogic. “This phenomenon is driving down delinquencies and fueling a boom in cash-out refinancing transactions.”

 

“The decline in the overall delinquency rate to its lowest since the onset of the pandemic is good News but it masks the serious financial challenges that some of the borrower population has experienced,” said Dr. Frank Nothaft, chief economist at CoreLogic. “In the months prior to the pandemic, only one-in-five delinquent loans had missed six or more payments. This August, one-in-two borrowers with missed payments were behind six-or-more monthly installments, even though the overall delinquency rate had declined to the lowest level since March 2020.”

 

State and Metro Takeaways:

  • In August 2021, all states saw year over year declines in their overall delinquency rate. New Jersey (down 4.0 percentage points); Florida (down 3.8 percentage points); and Nevada (down 3.6 percentage points), saw the largest year over year declines. All other states experienced decreases between -1.3 and -3.3 percentage points.
  • All U.S. metropolitan areas posted at least a small annual decrease in their overall delinquency rate. The largest annual decreases were in Laredo, Texas (down 6.3 percentage points), Miami-Fort Lauderdale-Pompano Beach, Florida (down 5.7 percentage points), McAllen-Edinburg-Mission, Texas (down 5.3 percentage points) and Atlantic City-Hammonton, New Jersey (down 5 percentage points).

 

The next CoreLogic Loan Performance Insights Report will be released on December 14, 2021, featuring data for September 2021. For ongoing housing trends and data, visit the CoreLogic Intelligence Blog: www.corelogic.com/intelligence.

 

Methodology

The data in The CoreLogic LPI report represents foreclosure and delinquency activity reported through August 2021. The data in this report accounts for only first liens against a property and does not include secondary liens. The delinquency, transition and foreclosure rates are measured only against homes that have an outstanding mortgage. Homes without mortgage liens are not subject to foreclosure and are, therefore, excluded from the analysis. CoreLogic has approximately 75% coverage of U.S. foreclosure data.

 

About the CoreLogic Consumer Housing Sentiment Study

3,000+ consumers were surveyed by CoreLogic via Qualtrics. The study is an annual pulse of U.S. housing market dynamics concentrated on consumers looking to purchase a home, consumers not looking to purchase a home, and current mortgage holder. The survey was conducted in April 2021 and hosted on Qualtrics. The survey has a sampling error of~3% at the total respondent level with a 95% confidence level.

 

Source: CoreLogic

The data provided is for use only by the primary recipient or the primary recipient’s publication or broadcast. This data may not be re-sold, republished or licensed to any other source, including publications and sources owned by the primary recipient’s parent company without prior written permission from CoreLogic. Any CoreLogic data used for publication or broadcast, in whole or in part, must be sourced as coming from CoreLogic, a data and analytics company. For use with broadcast or web content, the citation must directly accompany first reference of the data. If the data is illustrated with maps, charts, graphs or other visual elements, the CoreLogic logo must be included on screen or website. For questions, analysis or interpretation of the data, contact Amy Brennan at newsmedia@corelogic.com. Data provided may not be modified without the prior written permission of CoreLogic. Do not use the data in any unlawful manner. This data is compiled from public records, contributory databases and proprietary analytics, and its accuracy is dependent upon these sources.

 

About CoreLogic

CoreLogic is a leading global property information, analytics and data-enabled solutions provider. The company’s combined data from public, contributory and proprietary sources includes over 4.5 billion records spanning more than 50 years, providing detailed coverage of property, mortgages and other encumbrances, consumer credit, tenancy, location, hazard risk and related performance information. The markets CoreLogic serves include real estate and mortgage finance, insurance, capital markets, and the public sector. CoreLogic delivers value to clients through unique data, analytics, workflow technology, advisory and managed services. Clients rely on CoreLogic to help identify and manage growth opportunities, improve performance and mitigate risk. Headquartered in Irvine, Calif., CoreLogic operates in North America, Western Europe and Asia Pacific. For more information, please visit www.corelogic.com.

 

CORELOGIC and the CoreLogic logo are trademarks of CoreLogic, Inc. and/or its subsidiaries. All other trademarks are the property of their respective owners.

Contacts

Amy Brennan

CoreLogic

newsmedia@corelogic.com